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ABSTRACT 
Beyond prompt irradiation, 137Cs is likely to be the most biologically important agent released 
in many accidental (or malicious) radiation exposure scenarios. 137Cs either can enter the food 
chain or be consumed or if present in the environment (e.g. fallout) can provide external irradiation. 
In either case, due to the high penetration of the 662 keV γ rays emitted by 137Cs, the individual 
will be exposed to a uniform, whole body, irradiation at low dose rates.  
The VADER (VAriable Dose-rate External 137Cs irradiatoR) allows modeling these exposures, 
bypassing many of the problems inherent in internal emitter studies. Making use of discarded 137Cs 
brachytherapy seeds, the VADER can provide varying low dose rate irradiations at dose rates of 
0.1 to 1.2 Gy/day. The VADER includes a mouse “hotel”, designed to allow long term 
simultaneous residency of up to 15 mice. Two source platters containing ~250 mCi each of 137Cs 
brachytherapy seeds are mounted above and below the cage and can be moved under computer 
control to provide constant low dose rate or a varying dose rate mimicking 137Cs biokinetics in 
mouse or man. We present the VADER design and characterization of its performance.   
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INTRODUCTION 
In many large-scale radiation exposure scenarios, internal or external exposure to 137Cs is often 
the major source of radiation exposure [1-3]. 137Cs is generated in large quantities by fission and 
is one of the major sources of contamination following reactor accidents [3] and in nuclear fallout, 
for ground burst nuclear detonations [4] but not for air burst scenarios [5]. Due to its ubiquity in 
industrial irradiation systems, it presents a hazard for both malicious and accidental exposures 
(similar to the Goiânia accident [6]).  
137Cs is a water-soluble γ emitter with a physical half-life of 30 years. When released, it can 
readily be deposited on surfaces and enter the food chain [7, 8]. Because of its environmental 
persistence and ease of dispersal, 137Cs poses a significant risk to the general public. It is therefore 
important to develop biological assays for identifying individuals exposed to internal or 
environmental 137Cs. With external exposures, following an improvised nuclear device (IND) for 
example, dose rates may be initially high, depending on the level of shielding and distance from 
the detonation [9], and decrease rapidly with time [10], following the so called 7-10 rule [11]. 
Typical exposure durations are on the order of 48 h to 1 week, depending on the time required for 
evacuation, and doses of multiple Gy are possible [9].   
In the case of internal exposures, dose rates are typically much lower [4] but the persistence 
may be much higher: 137Cs permeates all tissues and is cleared over a period of months [12] 
(although chelating agents somewhat accelerate its clearance [13]), accumulating damage to 
tissues and particularly to the genetic material, which may result in delayed disease. Thus, in the 
event of a large-scale accidental or malicious release of volatile radionuclides, resulting in internal 
or external exposures, there is an important need to develop radiation biodosimetry assay(s) and 
technologies for population-based triage and subsequent dose-dependent medical management [2]. 
Over the past decade, we have utilized 137CsCl(aq) injection in mice to study the long-term effects 
of ingested 137Cs on cytogenetic [14, 15], transcriptomic [16] and metabolomic [17, 18] endpoints. 
The difficulty of these studies lies in the fact that both the study animals and the resulting biofluids 
are often radioactive and require dedicated equipment to analyze, making systematic studies 
difficult and expensive. At this time, only one or two laboratories in the US have the appropriate 
facilities and highly trained personnel that are required for conducting these 137Cs injection studies. 
As the majority of dose delivered from this type of exposure is due to long range γ rays [19] 
(Half Value Layer : 82 mm in water [20]), the physical dose distribution will be very similar for 
internal vs. external exposures. Thus, it is possible to model internal exposures (e.g. from ingested 
fallout) using an external isotope source, provided it is properly modulated to model biokinetics 
[21].  
We have developed the VADER (VAriable Dose-rate External 137Cs irradiatoR) to facilitate 
modeling of low dose rate 137Cs exposures either from ingested or fallout exposures. The VADER 
irradiator is based on “repurposing” of old 137Cs brachytherapy seeds. These seeds were much used 
starting in the 1980s to treat cervical cancer at low dose rate [22], but are no longer in use clinically 
and so the seeds are kept in long-term storage, making them available for research use. At 
Columbia University, we had available a few dozen such sources, ranging from 3 to 35 mCi each. 
We describe below the construction and first tests of the VADER system, culminating in several 
30-day mouse irradiations, mimicking the internal exposure experiments described in [15-18]. 
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VADER DESIGN 
Overview 
 
Fig 1. The VADER structure before installation of the shielding  
The VADER system (shown in Figure 1) was designed around the requirement to house 15 
mice at a time in an environment with dose rates of up to approximately 1 Gy/day over a period of 
several weeks. The VADER geometry was therefore dictated by the size of the mouse “hotel”. 
Within the hotel, mice are free to move around, eat and drink ad libitum. Temperature, humidity, 
airflow and lighting are fully controlled to the required animal care standards. Shielding is 
provided by a mixture of lead and high-density concrete bricks as described below.  
Approximately 0.5 Ci of 137Cs brachytherapy seeds, housed in two platters (above and below 
the mouse hotel), can be moved from almost touching the mouse hotel to about 60 cm above and 
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below it, allowing a time-variable dose rate to be implemented. Arrangement of the sources within 
the platter was optimized to achieve as uniform as possible a radiation field at about 1 Gy/day.  
A feature of the VADER is that there are no fixed active components within the VADER 
enclosure. All environmental controls and monitoring are integrated into the removable mouse 
hotel so that they can be easily replaced in case of radiation damage. This is significantly cheaper 
and easier than using radiation hardened sensors and electronics. Similarly, the motors driving the 
source holders are placed outside the shielding and the platters are moved using steel cables and 
pulleys. 
Design of the mouse hotel 
A custom mouse hotel (Fig. 2) was designed with the goal of housing up to 15 mice for 5-7 
days at a time (with longer residencies requiring cage cleaning and replenishment of food and 
water). The hotel therefore consists of a 35 cm x 35 cm x 12 cm acrylic box in which the mice are 
free to move and interact with each other. Mice are able to eat and drink ad libitum from four all-
plastic, custom-made water bottles and reservoirs holding feed pellets placed behind glass rods. 
Sufficient bedding material is also provided within the mouse hotel. Real time monitoring of the 
mice is performed using a 180° fisheye USB camera (ELP, Amazon) embedded into one of the 
hotel walls. 
 
Figure 2: a) Photo and b) design drawing of the mouse hotel. Air inlet and outlet, feeders, illumination, 
temperature/humidity sensor and camera are indicated. The latter two are shown in close up in panel c). 
 Four mouse hotels were built: to allow two to be used simultaneously (one inside the VADER, 
and one for the zero dose control mice) and two spares to allow the weekly rapid transfer of the 
mice into a clean hotel with fresh bedding and replenished food and water.   
To monitor the environment in the mouse hotel, a temperature/humidity sensor (HWg HTemp, 
TruePath Technologies Victor, NY) is integrated into one of the hotel walls.  Medical grade air is 
piped into the hotel at a rate of 1.5 liter/min (10 volume changes/h). Used air is vented into the 
VADER enclosure through two 100 cm2 HEPA filters (M-Bar Filter, Allentown Inc, Allentown, 
NJ). A day-night light cycle is maintained by integrating Warm White (3100K) LEDs (SMD3528; 
LEDWholesalers, Hayward, CA) into the hotel walls. The LEDs are powered using an adjustable 
benchtop power supply (Laskar Electronics, Erie, PA), plugged into a Tork timer (Grainger, Lake 
Forest, IL). The timer was set to “on” between 8 AM and 8 PM and “off” between 8 PM and 8 
AM. Light intensity was adjusted to 60 lux. 
Design of the irradiation system  
When designing the source arrangement our goal was to achieve a maximal dose of 1 Gy/day 
(we can provide higher dose rates using a highly filtered X-ray machine [23]) with a uniformity of 
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±10% or better across the mouse hotel. As the VADER system is based on repurposing of existing 
137Cs brachytherapy seeds, we were limited to use available sources, which vary in age, intensity 
and physical dimensions. The seeds available to us ranged between 3 and 35 mCi, as verified using 
a well counter (HDR 1000 plus, Standard Imaging Inc, Middleton, WI), and were either 20.0 or 
21.0 mm long and between 3.1 and 3.2 mm in diameter.  
To model various source geometries and select the seed intensities and positions, we calculated 
the expected dose across the mouse hotel using a MATLAB script. We modeled each seed as two 
point sources 7 mm apart. The dose rate at a distance R from each half seed is given by 
𝐷𝑜𝑠𝑒 𝑟𝑎𝑡𝑒 [𝐺𝑦/𝑑𝑎𝑦] = 67.92
1
2 𝑆𝑒𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 [𝑚𝐶𝑖]
𝑅[𝑚𝑚]2
 
Where 67.92 is the dose rate in Gy/day, 1 mm away from a 1 mCi point source, obtained using 
the RadPro Calculator (http://www.radprocalculator.com/Gamma.aspx) and a quality factor of 1.  
 
Figure 3: a) The source arrangement used in VADER. b) MATLAB simulation of the dose rate obtained 
from this arrangement. The dashed line corresponds to the extents of the mouse hotel; each contour 
corresponds to a 5% variation in expected dose rate.  
The ideal source placement above and below the mouse hotel, within the geometric and source 
availability constraints is shown in Fig. 3. Eight sets of three 20 mm long seeds, totaling about 50 
mCi per set were placed above/below the four corners of the mouse cage and single 21 mm long 
10-17 mCi seeds at the centers of the edges and at the center of the cage. Using this geometry, the 
dose rate within the mouse cage was calculated to be uniform to within 20% at the highest nominal 
dose rate (1 Gy/day).  
Custom aluminum platters were designed to hold the seeds. Each platter (Fig. 4) consists of two 
layers of aluminum (3/16" and 1/8" thick) with pockets hollowed out for either three 20 mm long 
seeds (at the corners) or one 21 mm long seed (at the edge and platter centers). Grouping seeds by 
size in this way simplified the platter design and allowed tighter tolerances on the pocket lengths, 
preventing the seeds from shifting during use. Openings were made on both pieces so that while 
the seeds are captive, there is no material between the active portion of the seed and the mouse 
cage.   
The seeds were loaded into the platters using remote manipulators at Columbia University’s 
David A. Gardner PET Imaging Research Center. Once the seeds were loaded into the platter and 
the platter lid connected, the platters were loaded into a lead safe (Marshield, Burlington, ON) and 
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transported to the VADER location. Both loading the platters into the safe and transferring the 
platters into the VADER were achieved using a 5' long rod with a locking gripper, designed for 
this purpose, and supervised by Columbia University’s Radiation Safety Officer. 
 
Figure 4: The seed holder plate with seeds loaded at the hot cell. 
Within the VADER, the seed platters sit on a frame that is free to move along a vertical Steel 
rod, using linear ball bearings. Two Motors (AZM46MC-TS10, Oriental Motors USA Corp., 
Torrance, CA) are mounted outside the shielding, above the VADER. Each motor controls a spool 
of 3/32" ultra-flexible stainless steel wire rope (150 lb capacity, McMaster-Carr, Princeton, NJ) 
used to raise and lower the source platters.  
The stepper motors include an absolute mechanical encoder, allowing repeatable absolute 
positioning, without battery back-up or external sensors. The motors also include an 
electromagnetic brake, which activates when power is removed. This allows the source platter to 
stay in place (rather than falling) in the case of a power failure. A built in 10:1 Taper hobbed 
gearbox provides a torque of up to 2 Nm and a motion of 0.036 °/Pulse (17 cm/turn). Each motor 
is independently controlled by an AZD-AD Motor driver (Oriental Motors). The two drivers are 
daisy-chained and controlled by RS485 Modbus.  
A second steel cable connects each platter to an external weight and allows external verification 
of the source position, independent of the motor encoder. The motor encoders were configured 
such that they read zero (home) at the fully retracted position. This allows for a rapid retraction of 
the sources using the controller’s ZHOME (fast return to home) command. 
Shielding design 
Minimizing radiation exposure to the operators and other uninvolved personnel is a prime 
concern in the design of 137Cs-based irradiators.  Shielding for the VADER was designed to 
maintain radiation doses to occupationally exposed personnel (operators) in the room below 0.1 
mGy/wk and 0.02 mGy/wk to anyone outside the room, in accordance with the guidance of NCRP 
Report 151 [24]. This also allows non-irradiated, control, mice to be housed in the same room.      
The room where VADER is installed is below grade, such that the rear wall is the building’s 
perimeter foundation wall. Adjacent rooms to the east and west and above are uncontrolled areas 
and considered occupied by uninvolved personnel (i.e., general public).  An uncontrolled corridor 
borders the south side of the room. The walls are constructed of normal density concrete, 6" thick; 
the floor above is 4" of normal concrete. 
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In consultation with Columbia University’s Radiation Safety Office, we have determined the 
required shielding to be either 3" of lead or 12" of high density concrete (4.7 g/cm3; HDC). The 
side walls of VADER were built of two layers of 6"x6"x12" HDC interlocking bricks (Ultraray 
Inc, Oakville, ON, seen at the bottom of Fig. 1). Half bricks were used to offset the vertical seam 
every other row, to increase structural stability. An external aluminum frame was provided to 
increase lateral stability of the walls. The front and top faces of the VADER, however, required 
penetrations for inserting/removing the mouse hotel as well as for control cables and were therefore 
made of lead, which is much more expensive but can be machined. We used 1.5"x4"x12" 
interlocking lead bricks (Radiation Protection Products Inc. Wayzata, MN), similarly arranged in 
two layers with half bricks used to offset the seams. A custom sliding door made of a 3" thick lead 
slab, held in an aluminum frame was designed and built, to allow access to the mouse hotel. 
Although heavy, the door slides on rails and can be easily opened and closed with one hand. The 
rear face of the irradiator was not shielded as it abuts the north wall, is below grade and hence, 
there are no occupied spaces beyond.    
VADER control and monitoring 
Control software for the VADER was written in Visual C++ (Microsoft, Redmond, WA). The 
software consists of a single windows “form” that controls the source movement and camera as 
well as monitoring the temperature and humidity in the mouse hotel. The PC running the VADER 
control software was configured to allow for secure remote access to allow monitoring of VADER 
operations. 
As an experiment could last 30 days or more, it is crucial to allow recovery from unforeseen 
computer reboots (e.g. system updates or power failures). The VADER control software was 
therefore configured to automatically start at computer start up (prior to login) and maintain files 
containing the start time of irradiation and the required irradiation profile: a list of required source 
positions as a function of time. During operation, the control software periodically compares the 
elapsed time since the beginning of the experiment to this list, and verifies that the positions 
reported by the motors correspond to the required ones, moving the sources if necessary. The motor 
position and status as well as the temperature and humidity probe values, are displayed on screen 
and saved to a comma separated variable (csv) log file, which can be imported into excel.  
 
DOSIMETRY  
Offline dosimetry of the VADER was performed using an ionization chamber (10x6-6, Radcal 
Corp., Monrovia, CA). Following a background measurement outside the VADER the ionization 
chamber and electrometer were placed at the center of the mouse hotel and dose integrated for 5 
minutes at each retraction position. The required retraction as a function of dose rate was 
interpolated by fitting to a third order polynomial (Fig. 5). When monitoring VADER operations, 
the nominal dose rate was calculated based on the source position and ionization chamber results. 
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Figure 5: Dose rate as a function of reported motor position, measured using an ionization chamber. The 
dotted line is the fitted curve. 
   
Figure 6: Field uniformity, as measured using Gafchromic film at the highest dose rate (1.2 Gy/day). The 
four panels correspond to four 17.5cm square films exposed simultaneously, covering the entire mouse 
hotel area. Contours correspond to 0.5 Gy (roughly 5%) steps. 
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Dose uniformity was evaluated using EBT3 radiochromic film (Ashland Advanced Materials, 
Bridgewater, USA). Four 17.5cm square pieces of film were taped down at the bottom of the 
mouse hotel and exposed for several days. Films were scanned on a 48 Bit RGB Epson Perfection 
V700 Photo flatbed scanner (Epson, Japan), with a resolution of 300 dpi. We used the web 
application radiochromic.com [25] to analyze the films. The program used a set of calibration 
films, obtained by exposing film to known doses of 250 kVp x-rays, to define a relationship 
between the optical density of the three colors and a given dose. The two-dimensional dose 
distribution for a given film could then be determined using this relationship with high accuracy. 
Figure 6 shows the dose uniformity across the surface are of the mouse hotel at the highest dose 
rate. Variation of measured dose across the film is 10% (standard deviation). Hot spots are evident 
near the 50 mCi source clusters at the highest dose rates. These average out as the sources retract 
from the cage at 1 Gy/day the standard deviation across the cage was reduced to 3.5%.  
In vivo dosimetry was performed on a mouse-by-mouse basis, by injecting a glass encapsulated 
TLD chip into each mouse [26]. TLD rods were then read using a Harshaw 2500 TLD reader 
(Thermo Fisher Scientific), most experiments used a heating profile consisting of a 5 °C/sec ramp 
up to 300 °C followed by a short hold at 300 °C and cool down to 50 °C. Dose was reconstructed 
based on the integrated light yield at a temperature higher than 180 °C to eliminate the low 
temperature, time dependent, glow peak.  
       
MOUSE STUDIES 
All animal experiments were approved by the Columbia University Institutional Animal Care 
and Use Committee (IACUC; approved protocol AAQ2410) and were conducted under all relevant 
federal and state guidelines. 
 Before starting any biological study for biodosimetry endpoints, we placed 15 mice into the 
mouse hotel and monitored them over 2 weeks. No weight loss and normal food and water 
consumption was found.  Initially, the mice were exploratory in the new environment and after 
about 30 minutes settled down. Similar behavior was observed in the VADER experiments.  
Mouse handling 
For a typical experiment, 30 (15 irradiated and 15 control, randomly assigned) 7 week old 
C57BL/6J “cage mate” mice were purchased from Charles River Laboratories (Frederick, MD) 
and kept at the Columbia University Irving Medical Center animal facility for one week of 
adaptation. Glass-encapsulated TLD rods [26] were injected at 8 weeks of age as follows:  
Anesthesia was induced with 2% isoflurane delivered in 100% oxygen for <3 min 
before the implantation procedure. The encapsulated TLD rods (one per mouse) were 
placed in a 12-gauge needle coupled with a needle injector (Allflex, Irving, TX) and 
administered by subcutaneous injection in the dorsal neck. Following implantation 
mice were monitored up to 48 hours for complications. 
Animals were then placed in the VADER, provided with food and water ad libitum and kept on 
a 12:12 hour light-dark schedule. For exposures longer than 1 week, the mouse hotel was removed 
from the VADER and mice transferred to a clean hotel with fresh bedding, food and water every 
5-7 days. During this transfer, mice were outside the irradiator for a total of 5 min.  Control mice 
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were placed in an identical cage in the same room and were transferred to a clean hotel roughly an 
hour before the irradiated mice. Temperature and humidity were monitored in both hotels. 
Cell counts 
Peripheral whole blood samples were collected at euthanasia from each mouse by cardiac 
puncture using a heparin-coated syringe. The spleen was excised and homogenized and the isolated 
splenocytes were suspended in PBS 2% FBS. Cell counts were determined by flow cytometry 
(CytoFLEX, Beckman Coulter, Pasedena, CA) using 20 μl of heparinized blood or 20 μl of spleen 
suspension stained with mouse CD45 antibody (WBC marker, clone 30-F11, eBioscience, San 
Diego, CA). 
Apoptosis  
Peripheral blood cells and splenocytes were fixed using the FIX & PERM™ Cell 
Permeabilization Kit (Thermo Fisher Scientific™, Waltham, MA) and stained with nuclear dye 
DRAQ5 (Thermo Fisher Scientific™, Waltham, MA). The cells were measured using the 
ImageStream®X Mark II Imaging Flow Cytometer (LUMINEX Corporation, Austin, Texas). 
Images of 5000 cells per sample were acquired at 40X magnification using the 488 nm excitation 
laser. Captured images were analyzed using IDEAS® (LUMINEX Corporation, Austin, Texas) 
software for measuring proportion of apoptotic cells, as identified by automated image analysis 
based on nuclear imagery features in combination with bright field morphology [27].  Data was 
expressed as mean and standard deviation and were analyzed using GraphPad Prism 6.0 (GraphPad 
Software, San Diego, CA, USA). The Kruskal-Wallis test was performed to compare data among 
all study groups. The Mann-Whitney U test was used to compare between two groups. P < 0.05 
was considered statistically significant.  
One Week Study 
The first VADER experiment focused on system validation. Twelve mice were housed in the 
VADER mouse hotel (with three controls in a second hotel, in the same room).  The VADER was 
programmed to produce the dose profile show in Figure 7 and Table 1, mimicking the dose and 
dose rate kinetics after injection of 6.66MBq 137CsCl(aq)  [15]). Four irradiated and one control 
mouse were sacrificed on days 1, 4 and 7. Blood leukocyte and splenocyte cell counts (CD45+ 
cells) are shown in Figure 8. As expected, the cell counts decreased with increasing absorbed dose 
 
Figure 7: VADER programming. The solid curve (left 
axis) displays the target dose rate as a function of 
time. The dashed curve (right axis) displays the 
target cumulative dose as a function of time.  
Table 1: Dose rates and doses for the one week 
study. 
Day Dose rate 
[Gy/day] 
Nominal 
Dose [Gy] 
Average 
TLD dose 
[Gy] 
1 0.84 0.87 0.66±0.03 
4 0.6 3.1 2.5±0.3 
7 0.36 4.5 4.33±0.14 
 
11 
 
over the irradiation period. Due to the large variation in the control mice, only the day 7 leukocyte 
and splenocyte counts were significantly lower than the control (p<0.05).  
The apoptosis frequency in the mouse peripheral blood leukocytes and splenocytes, 
respectively is shown in Figure 9. Although the overall rate of formation of apoptotic cells was 
relatively low (<3%), there was a significant (p<0.05) increase in apoptotic blood leukocytes by 
day 7 (dose = 4.33 Gy) and in splenocytes by day 4 (dose = 2.5 Gy) and a further increase by day 
7.  
 
Figure 8: Leukocyte (CD45+) counts in a) peripheral blood and b) spleen, following irradiation using the 
protocol shown in Figure 7. Symbols correspond to individual mice, the center line and error bars are 
average and Standard deviation. Asterisk denotes p<0.05 compared to control. 
 
Figure 9: Fold change of apoptotic cells in a) peripheral blood and b) spleen, following irradiation using the 
protocol shown in Figure 7. Symbols correspond to individual mice, the center line and error bars are 
average and Standard deviation. Asterisk denotes p<0.05 compared to control. 
One month study 
 Figure 10 shows the measured dose, dose rate, temperature and humidity during one of the 30 
day studies. As the VADER mouse hotel is limited to a capacity of 15 mice, experiments were run 
separately for the early and late time points. Fig 10 shows a run where time points of 5, 20 and 30 
days were assessed.       
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The measured dose rate, reconstructed from source position, was confirmed by the per-mouse 
TLD dosimetry and matched the required dose points. Temperature and humidity were within the 
accepted parameters. The decline in humidity is likely due to removal of 1/3 of the mice on days 
5 and 20 (air flow into the mouse hotel was not humidified).     
 
Figure 10: a) Dose rate (solid line, right axis) and cumulative dose (dashed line, left axis) calculated from 
source position over a 30-day study. The vertical lines in the dose rate curve correspond to brief VADER 
openings for cage cleaning and removing mice for analysis. Symbols at days 2, 3, 5, 20 and 30 are 
individual TLD readings for 5 mice at each time point (open symbols from a separate 5-day study using the 
same dose profile, conducted immediately prior to the 30-day study). b) Measured humidity (thick purple 
line, left axis) and temperature (thin blue line, right axis) in one of the cages used for the VADER. The gaps 
represent times when a different cage was used.    
 
Table 2: Dose rates and doses for the 30-day study. The TLD average and standard deviation dose based 
on 5 mice each. P values are based on an unpaired t test, comparing to controls.   
Day Dose rate 
[Gy/day] 
Nominal 
Dose [Gy] 
Average TLD 
dose [Gy] 
Leukocyte 
counts 
p value 
Control 0 0 -0.05±0.08 2300±800 NA 
2 0.82 1.9 1.6±0.1 1100±300 0.005 
3 0.72 2.7 2.3±0.1 1000±800 0.007 
5 0.59 4.0 3.7±0.1 800±400 0.0004 
20 0.14 8.7 8.7±0.2 1100±400 0.003 
30 0.10 9.8 9.95±0.2 1300±600 0.002 
 
Figure 11 and Table 2 show the leukocyte counts for this study, which declined similarly to 
those in Figure 8a with the beginning of recovery evident at Day 20-30. The main goal of this 
experiment was to mimic the injected 137Cs experiments reported previously [16], indeed, both the 
cumulative doses and the pattern of up and down regulated genes seen in that study was reproduced 
in this experiment (manuscript in preparation). 
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Figure 11: Leukocyte (CD45+) counts at various times during a 30-day study. Symbols correspond to 
individual mice, the center line and error bars are average and standard deviation. Single, double and triple 
asterisks denote p<0.05, p<0.001 and p<0.001, compared to control, respectively. 
 
Discussion 
We present here a novel low-dose-rate irradiator based on re-purposed 137Cs brachytherapy 
seeds. The irradiator was designed to mimic internal or external exposures from high level 
environmental 137Cs contamination, resulting in chronic exposures of Gy-level doses over days to 
weeks of exposure. Thus the VADER was designed to provide dose rates of 0.1-1 Gy/day. 
Obtaining a wider range of doses can be achieved by building a taller structure, allowing the 
sources to be retracted further from the mice, but due to the 1/r2 decrease of dose rate the system 
would have to be too tall to fit in a standard room to gain significantly in this respect. Another 
option, for achieving lower dose rates, if required, is to remove some of the seeds or replace them 
with weaker ones, essentially scaling down all doses.     
Alternate Technologies 
The Howell group have demonstrated the validity of modeling internal 137Cs exposures with 
external exposures using a cabinet type 137Cs irradiator coupled to a computer controlled mercury 
attenuator [28, 29]. In their system a mercury reservoir is placed between an 18 Ci 137Cs source 
and one or more cages holding four mice each. The amount of mercury in the reservoir can be 
modified, attenuating the γ-ray flux to achieve dose rates between approximately 10-4 and 0.25 
Gy/h [28].  This setup has been routinely used for calibration studies for internal emitter biomarker 
studies [30-32].  
An alternate approach to attenuation, which may alter the energy spectrum of the source, is to 
place the source very far from the animals to be irradiated. An example of this approach is the 
NMBU FIGARO low dose rate facility in Norway [33]. FIGARO utilizes a 60Co source, providing 
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a dose rate between 1 Gy/h, just outside the collimator and 0.4 mGy/h, 20 meters away. The 
obvious drawback of such a system is that it requires a very large facility, which is not suited to 
an urban university/medical center. FIGARO also does not currently provide variable dose rates, 
though they could be easily achieved by periodically moving the animal cages. As dose rate varies 
with the distance from the source, care needs to be taken that the animals cannot move too much 
in this direction. This is not a huge problem when irradiating at a source distance of 20 m but 
becomes problematic for higher dose rates that require source distances of 1-2 m. 
VADER performance 
General 
At the time of writing this paper the VADER has been in operation for over 9 months, including 
two 30-day studies and seven 7-day studies, for the study of cytogenetic, transcriptomic, and 
metabolomic endpoints. In addition to the design and dosimetry validation of the VADER we 
presented here blood count and apoptosis data from one 7 day study and one 30-day study. 
Additional manuscripts focusing on these different endpoints will be presented elsewhere. It 
should be noted that in our prior injection-based studies we were not able to access hematological 
data (especially at earlier time points) as the blood was too radioactive to analyze. Use of the 
VADER obviates this problem. 
 In the first pilot study (conducted in August 2018) the temperature in the VADER ranged from 
26 °C to 30 °C. Temperature in the control cage was slightly lower (23 °C to 29 °C), although both 
were somewhat warmer than the recommended temperatures for housing mice. Humidity in both 
hotels ranged from 40% to 60%. Following this week-long experiment, a second air conditioning 
unit was installed in the room, lowering summer temperatures to more acceptable levels.  
During this pilot study we also discovered several errors in data logging, which were corrected. 
One power outage had been experienced, but the VADER control software had recovered 
successfully and resumed operation when the power was restored.  
Dosimetry 
An important aspect of performing these long-term 
studies, where mice are free to roam in a (possibly) 
spatially varying radiation field is individualized 
dosimetry. We have developed an in vivo dosimetry 
technique [26], based on glass encapsulated TLD rods. 
The glass encapsulation allows the TLDs to be injected 
into mice without being damaged by the surrounding 
biofluids, while also allowing readout and annealing in 
the encapsulated state.  
  Figure 12 demonstrates in vivo measured doses, 
reconstructed using the TLDs, as a function of the 
nominal (requested) dose. The data show good agreement 
at the higher doses but the TLD doses were slightly lower 
than nominal at the lower doses. This may be due to the 
fact that most low doses were delivered in a short time 
using the highest dose rate setting, where there is 
Figure 12: TLD reconstructed doses (in 
Gy) for mice irradiated in the VADER. 
Each point corresponds to an individual 
mouse dose. The dashed line is the 
identity and the dotted lines are ±10%. 
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considerable spatial variation of dose at dose rates above 1 Gy/day, and it is possible that mice 
spent more time in the lower dose areas.   
   
Conclusions 
We describe a low dose irradiation facility based on repurposed 137Cs brachytherapy seeds. The 
VADER provides dose rates between 0.1 and 1.2 Gy/day to up to 15 mice at a time. Environmental 
conditions suitable for housing mice are maintained in the VADER for weeks at a time allowing 
protracted experiments with short weekly breaks for cage cleaning and food/water replenishment.  
The system is currently in routine use at Columbia University and can reproduce the results of 
137Cs injection experiments without the complications and costs involved in the handling of 
radioactive reagents, animals, and biofluids.  
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